Bristol-Myers Squibb Co
BMV:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
BMV:BMY
Watchlist
Price: 1 005 MXN -0.5% Market Closed
Market Cap: 105.4B MXN

Wall Street
Price Targets

BMY Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BMY stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMY is 974.8 MXN with a low forecast of 607.16 MXN and a high forecast of 1 296.74 MXN.

Lowest
Price Target
607.16 MXN
40% Downside
Average
Price Target
974.8 MXN
3% Downside
Highest
Price Target
1 296.74 MXN
29% Upside
Bristol-Myers Squibb Co Competitors:
Price Targets
GLENMARK
Glenmark Pharmaceuticals Ltd
9% Upside
LLY
Eli Lilly and Co
3% Upside
ANCR
Animalcare Group PLC
32% Upside
APLLTD
Alembic Pharmaceuticals Ltd
32% Upside
2005
SSY Group Ltd
30% Upside
VETO
Vetoquinol SA
8% Upside

Revenue
Forecast

Revenue Estimate
Bristol-Myers Squibb Co

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 7%. The projected CAGR for the next 4 years is -4%.

7%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bristol-Myers Squibb Co

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 4%. The projected CAGR for the next 4 years is 5%.

4%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Bristol-Myers Squibb Co

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BMY's stock price target?
Price Target
974.8 MXN

According to Wall Street analysts, the average 1-year price target for BMY is 974.8 MXN with a low forecast of 607.16 MXN and a high forecast of 1 296.74 MXN.

What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 7%. The projected CAGR for the next 4 years is -4%.

What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 4%. The projected CAGR for the next 4 years is 5%.

Back to Top